Research Article
Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis
Table 1
Potential effective compounds of Panax notoginseng.
| | Compound | OB% | DL | Degree | Structure |
| 1 | Quercetin | 46.43 | 0.28 | 238 | | 2 | Beta-sitosterol | 36.91 | 0.75 | 121 | | 3 | Gossypetin | 35 | 0.31 | 102 | | 4 | Stigmasterol | 43.83 | 0.76 | 96 | | 5 | Ginsenoside Rg1 | 9.03 | 0.28 | 46 | | 6 | Ginsenoside Rh2 | 36.32 | 0.56 | 41 | | 7 | Mandenol | 42 | 0.19 | 40 | | 8 | Ginsenoside Rb1 | 6.24 | 0.04 | 38 | | 9 | Rutaecarpine | 40.3 | 0.6 | 36 | | 10 | Ginsenoside Rb2 | 6.02 | 0.04 | 28 | | 11 | Notoginsenoside R1 | 4.27 | 0.13 | 26 | | 12 | 2-Hydroxy-3-formyl-7-methoxycarbazole | 83.08 | 0.18 | 10 | | 13 | Dihydrorutaecarpine | 42.27 | 0.6 | 4 | | 14 | Ginsenoside F2 | 36.43 | 0.25 | 3 | |
|
|